OIG Confirms 340B Guidance Is Silent on Medicaid MCO Duplicate Discounts

by Admin | April 30, 2014 10:34 am

April 30, 2014—Federal 340B contract pharmacy guidance “does not specify” whether covered entities are responsible for ensuring that states do not collect manufacturer rebates for 340B-purchased drugs reimbursed by Medicaid managed care organizations, the Department of Health and Human Services Office of Inspector General says in a letter to two 340B provider groups.

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1]. Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:

Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2014/04/oig-confirms-340b-guidance-is-silent-on-medicaid-mco-duplicate-discounts/